Rapid identification with pharmacist-driven reporting is associated with which change in antibiotic management?

Rapid identification with pharmacist-driven reporting is associated with which change in antibiotic management?

• A. Reduced time to antibiotic change
• B. Increased time to antibiotic change
• C. No change
• D. More broad-spectrum use

Answer: (A)

Rapid identification paired with pharmacist-driven reporting speeds up antimicrobial optimization. When a pathogen is identified quickly and pharmacists actively relay the results to the treating team, clinicians can move from broad empiric therapy to a targeted regimen sooner. This often means de-escalating to a narrower-spectrum antibiotic, adjusting the dose or route, or stopping unnecessary agents earlier in the course. The result is a shorter interval before a change in therapy is made. The other scenarios—delays, no change, or increased broad-spectrum use—don’t align with the impact of rapid identification combined with proactive pharmacist involvement, which is to accelerate appropriate antibiotic modification.

Rapid identification paired with pharmacist-driven reporting speeds up antimicrobial optimization. When a pathogen is identified quickly and pharmacists actively relay the results to the treating team, clinicians can move from broad empiric therapy to a targeted regimen sooner. This often means de-escalating to a narrower-spectrum antibiotic, adjusting the dose or route, or stopping unnecessary agents earlier in the course. The result is a shorter interval before a change in therapy is made. The other scenarios—delays, no change, or increased broad-spectrum use—don’t align with the impact of rapid identification combined with proactive pharmacist involvement, which is to accelerate appropriate antibiotic modification.